Literature DB >> 7522544

Common region of deletion on the long arm of chromosome 6 in non-Hodgkin's lymphoma and acute lymphoblastic leukaemia.

L P Menasce1, V Orphanos, M Santibanez-Koref, J M Boyle, C J Harrison.   

Abstract

We have used fluorescence in situ hybridisation (FISH) with a series of yeast artificial chromosome (YAC) clones that map to the long arm of chromosome 6 (6q) to define the region(s) of deletion in seven cases of non-Hodgkin's lymphoma (NHL), in which a deletion of 6q had been detected by conventional cytogenetics. The FISH analysis detected two regions of deletion: (i) A proximal region flanked by M6P1 (6q14-15) and FYN (6q21), containing D6S246, which was missing in all seven cases. This locus was also found to be deleted in all six cases of acute lymphoblastic leukaemia (ALL) studied previously. (ii) A second region of 6q, which was distal to 6q23.1 (D6S238) and included ESR (6q25.1) and D6S281 (6q27), which was shown to be present in all our cases of ALL, was found to be deleted in 4 of the 7 cases of NHL. Our results support the suggestion that tumour suppressor genes, involved in the pathogenesis of lymphoid malignancies, may be present within these regions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522544     DOI: 10.1002/gcc.2870100411

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  11 in total

1.  Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.

Authors:  S F Huang; S Xiao; A A Renshaw; K R Loughlin; T J Hudson; J A Fletcher
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

2.  Analysis of chromosome 6 deletions in lymphoid malignancies provides evidence for a region of minimal deletion within a 2-megabase segment of 6q21.

Authors:  T Sherratt; C Morelli; J M Boyle; C J Harrison
Journal:  Chromosome Res       Date:  1997-04       Impact factor: 5.239

3.  A radiation hybrid panel for human chromosome 6q.

Authors:  V Orphanos; M Greaves; M Santibanez-Koref; M Fox; Y H Edwards; J M Boyle
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

4.  Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

5.  Chromosome 6 suffers frequent and multiple aberrations in thymoma.

Authors:  Masayoshi Inoue; Alexander Marx; Andreas Zettl; Philipp Ströbel; Hans-Konrad Müller-Hermelink; Petr Starostik
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

6.  Loss of heterozygosity at the mannose 6-phosphate insulin-like growth factor 2 receptor gene correlates with poor differentiation in early breast carcinomas.

Authors:  S A Chappell; T Walsh; R A Walker; J A Shaw
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Fluorescent polymerase chain reaction of a panel of CA repeats on chromosome 6 in the indolent phase of follicular centre cell lymphoma.

Authors:  J Randerson; L Cawkwell; A Jack; F Lewis; P Johnson; P Evans; S Barrans; G J Morgan
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640

8.  The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer.

Authors:  Ying Liu; Phillippa Dodds; Gracy Emilion; Andrew J Mungall; Ian Dunham; Stephan Beck; R Spencer Wells; F Mark L Charnock; Trivadi S Ganesan
Journal:  BMC Genet       Date:  2002-10-15       Impact factor: 2.797

9.  WT1-associated protein is a novel prognostic factor in pancreatic ductal adenocarcinoma.

Authors:  Bing-Qi Li; Shuai Huang; Qian-Qian Shao; Jian Sun; Li Zhou; Lei You; Tai-Ping Zhang; Quan Liao; Jun-Chao Guo; Yu-Pei Zhao
Journal:  Oncol Lett       Date:  2017-02-28       Impact factor: 2.967

10.  Allelic imbalance of chromosome 6q in ovarian tumours.

Authors:  V Orphanos; G McGown; Y Hey; M Thorncroft; M Santibanez-Koref; S E Russell; I Hickey; R J Atkinson; J M Boyle
Journal:  Br J Cancer       Date:  1995-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.